Catalyst Wire Dossier Catalyst Wire Dossier

Apotex Ciclesonide Nasal Spray

ciclesonide · Apotex Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Apotex Ciclesonide Nasal Spray, covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis [Phase 3]

See pricing